Stay up to date with news and events
Wave Life Sciences Announces Positive Results from Phase 1B/2A SELECT-HD Trial
June 26, 2024
Great news on the positive results! Read all the details below. Community Letter Press Release
No pivot needed for PTC-518
June 22, 2024
On June 20, 2024, we received an update from PTC Therapeutics about their ongoing trial, PIVOT-HD. PIVOT is testing PTC-518, a small molecule drug, taken…
SURVEYOR opens the door for drugs that treat cognition
June 14, 2024
Sage Therapeutics released a press statement on June 11th that focuses on the main results of a study called SURVEYOR, aimed at studying cognition (thinking)…
The VIP section: velvet ropes for the brain and how to get in
June 12, 2024
Two separate research groups recently published work on the blood-brain barrier (BBB). You can think of the BBB like a bouncer that keeps the riffraff…
Two birds, one stone: HTT-lowering drugs also target CAG expansions
May 21, 2024
Huntingtin (HTT)-lowering and somatic expansion have been two of the hottest topics in Huntington’s disease (HD) research in the past decade. Recent work from a…